Search Results

There are 7683 results for: content related to: Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

  1. You have free access to this content
    Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial

    BJU International

    Volume 113, Issue 2, February 2014, Pages: 254–259, Paul F. Pinsky, Howard L. Parnes and Gerald Andriole

    Version of Record online : 21 NOV 2013, DOI: 10.1111/bju.12368

  2. You have free access to this content
    Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

    International Journal of Cancer

    Volume 97, Issue 2, 10 January 2002, Pages: 237–244, Harry J. de Koning, Anssi Auvinen, Antonio Berenguer Sanchez, Fernando Calais da Silva, Stefano Ciatto, Louis Denis, John K. Gohagan, Matti Hakama, Jonas Hugosson, Ries Kranse, Vera Nelen, Philip C. Prorok, Fritz H. Schröder and ERSPC and the PLCO Trials (the International Prostate Cancer Screening Trials Evaluation Group)

    Version of Record online : 8 OCT 2001, DOI: 10.1002/ijc.1588

  3. Prostate-specific antigen screening: A critical review of current research and guidelines

    Journal of the American Association of Nurse Practitioners

    Volume 26, Issue 10, October 2014, Pages: 574–581, James G. Robinson, Eric. A. Hodges and Jean Davison

    Version of Record online : 8 JAN 2014, DOI: 10.1002/2327-6924.12094

  4. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years

    Cancer

    Volume 123, Issue 4, February 15, 2017, Pages: 592–599, Paul F. Pinsky, Philip C. Prorok, Kelly Yu, Barnett S. Kramer, Amanda Black, John K. Gohagan, E. David Crawford, Robert L. Grubb and Gerald L. Andriole

    Version of Record online : 1 DEC 2016, DOI: 10.1002/cncr.30474

  5. You have free access to this content
    Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial

    International Journal of Cancer

    Volume 132, Issue 9, 1 May 2013, Pages: 2127–2133, Paul F. Pinsky, Claire Zhu, Steve J. Skates, Amanda Black, Edward Partridge, Saundra S. Buys and Christine D. Berg

    Version of Record online : 5 NOV 2012, DOI: 10.1002/ijc.27909

  6. You have free access to this content
    Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

    BJU International

    Volume 102, Issue 11, December 2008, Pages: 1524–1530, Robert L. Grubb III, Paul F. Pinsky, Robert T. Greenlee, Grant Izmirlian, Anthony B. Miller, Thomas P. Hickey, Thomas L. Riley, Jerome E. Mabie, David L. Levin, David Chia, Barnett S. Kramer, Douglas J. Reding, Timothy R. Church, Lance A. Yokochi, Paul A. Kvale, Joel L. Weissfeld, Donald A. Urban, Saundra S. Buys, Edward P. Gelmann, Lawrence R. Ragard, E. David Crawford, Philip C. Prorok, John K. Gohagan, Christine D. Berg and Gerald L. Andriole

    Version of Record online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.2008.08214.x

  7. Screening for prostate cancer

    Intervention Review

    The Cochrane Library

    Dragan Ilic, Molly M Neuberger, Mia Djulbegovic and Philipp Dahm

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD004720.pub3

  8. You have free access to this content
    Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials

    Cancer

    Volume 119, Issue 3, 1 February 2013, Pages: 593–601, Paul F. Pinsky, Amanda Black, Robert Grubb, E. David Crawford, Gerald Andriole, Ian Thompson and Howard Parnes

    Version of Record online : 14 AUG 2012, DOI: 10.1002/cncr.27774

  9. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1322–1328, Michael A. Liss, Jianfeng Xu, Haitao Chen and A.Karim Kader

    Version of Record online : 15 MAY 2015, DOI: 10.1002/pros.23012

  10. Screening for ovarian cancer: imaging challenges and opportunities for improvement

    Ultrasound in Obstetrics & Gynecology

    Accepted manuscript online: 22 JUN 2017, Kelsey B. Mathieu, Deepak G. Bedi, Sara L. Thrower, Aliya Qayyum and Robert C. Bast Jr.

    DOI: 10.1002/uog.17557

  11. You have free access to this content
    Screening for lung cancer

    Intervention Review

    The Cochrane Library

    Renée Manser, Anne Lethaby, Louis B Irving, Christine Stone, Graham Byrnes, Michael J Abramson and Don Campbell

    Published Online : 21 JUN 2013, DOI: 10.1002/14651858.CD001991.pub3

  12. Insights from the PLCO trial about prostate cancer screening

    Cancer

    Volume 123, Issue 4, February 15, 2017, Pages: 546–548, Roman Gulati and Peter C. Albertsen

    Version of Record online : 1 DEC 2016, DOI: 10.1002/cncr.30472

  13. You have free access to this content
    Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 91–100, Lee E. Moore, Ruth M. Pfeiffer, Zhen Zhang, Karen H. Lu, Eric T. Fung and Robert C. Bast Jr.

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26241

  14. You have free access to this content
    Cancer screening in the United States, 2013

    CA: A Cancer Journal for Clinicians

    Volume 63, Issue 2, March/April 2013, Pages: 87–105, Robert A. Smith, Durado Brooks, Vilma Cokkinides, Debbie Saslow and Otis W. Brawley

    Version of Record online : 1 FEB 2013, DOI: 10.3322/caac.21174

  15. Prostate Cancer Screening

    Cancer and Aging Handbook: Research and Practice

    Keith M. Bellizzi, Margot A. Gosney, Pages: 153–161, 2013

    Published Online : 2 JAN 2013, DOI: 10.1002/9781118312513.ch12

  16. You have free access to this content
    The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

    Cancer

    Volume 75, Issue S7, 1 April 1995, Pages: 1869–1873, John K. Gohagan, Philip C. Prorok, Barnett S. Kramer, Richard B. Hayes and Joyce E. Cornett

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19950401)75:7+<1869::AID-CNCR2820751617>3.0.CO;2-7

  17. Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer

    The Prostate

    Volume 77, Issue 2, February 1, 2017, Pages: 173–184, Azza Shoaibi, Gowtham A. Rao, Bo Cai, John Rawl, Kathlyn Sue Haddock and James R. Hébert

    Version of Record online : 4 OCT 2016, DOI: 10.1002/pros.23258

  18. You have free access to this content
    Who should be included in a clinical trial of screening for bladder cancer?

    Cancer

    Volume 119, Issue 1, 1 January 2013, Pages: 143–149, Andrew J. Vickers, Caroline Bennette, Adam S. Kibel, Amanda Black, Grant Izmirlian, Andrew J. Stephenson and Bernard Bochner

    Version of Record online : 26 JUN 2012, DOI: 10.1002/cncr.27692

  19. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort

    Head & Neck

    Volume 35, Issue 7, July 2013, Pages: 914–922, Mia Hashibe, Jason Hunt, Mei Wei, Saundra Buys, Lisa Gren and Yuan-Chin Amy Lee

    Version of Record online : 19 JUN 2012, DOI: 10.1002/hed.23052

  20. You have free access to this content
    Prostate-specific antigen-based prostate cancer screening: Past and future

    International Journal of Urology

    Volume 22, Issue 6, June 2015, Pages: 524–532, Arnout R Alberts, Ivo G Schoots and Monique J Roobol

    Version of Record online : 6 APR 2015, DOI: 10.1111/iju.12750